The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Poster Presentation(E) Pharmaceutical Health Care and Sciences

[28-57-pm1]Clinical pharmaceutical sciences 5, Pathophysiology (Cancer)

Sat. Mar 28, 2026 1:10 PM - 3:10 PM JST
Sat. Mar 28, 2026 4:10 AM - 6:10 AM UTC
Room 57 (C205, Bldg. 2, Area 2 [2F])
Discusser: Shin-ya Morita, Daiki Hira

[28-57-pm1-01S]Exploration of Novel Combination Therapies Based on Olaparib for Pancreatic Cancer

○Yohei Musha1, Yoshihito Morimoto1, Kotone Morimoto1, Osamu Takeuchi2, Kazuhiro Watanabe1, Masayoshi Hirohara1, Yutaka Masuda1 (1. Showa. Pharm. Univ., 2. Department of Research, Kitasato Institute Hospital)

[28-57-pm1-02S]A Basic Study on Targeting the DNA Damage Checkpoint Pathway in Gemcitabine-Resistant Human Pancreatic Cancer Cells

○Aika Matsumoto1, Yoshihito Morimoto1, Mako Fujimoto1, Karin Kuwamura1, Osamu Takeuchi2, Kazuhiro Watanabe1, Masayoshi Hirohara1, Yutaka Masuda1 (1. Showa. Pharm. Univ., 2. Dept. of Research, Kitasato Inst. Hosp.)

[28-57-pm1-03S]Hinesol, a compound isolated from essential oils of Atractylodes lancea rhizome, inhibits the cell growth and induces apoptosis in human leukemia HL-60 cells

○Mako Fujimoto1, Akinori Takagi1, Shigeo Akiyama1, Yutaka Masuda1 (1. Grad.Sch.Pharm.Showa. Pharm. Univ.)

[28-57-pm1-04S]Identification of a Tipping Point and Functional Gene Discovery through Time-Series Analysis of Epithelial–Mesenchymal Transition (EMT) in Human Lung Cancer Cells (A549)

○Miku Sugama1, Kosuke Hashimoto2,6, Kohei Kunimoto3, Rin Hiraishi4, Yuuri Hashimoto1, Shoei Suzuki1, Akinori Taketani6, Akane Hara1, Kazutaka Akagi5,6, Keiichi Koizumi5,6 (1. Pharm. Sci., Univ. of Toyama, 2. RIKEN, 3. Faculty of Med., Univ. of Toyama, 4. Grad. Sch. of Med. and Pharm. Sci., Univ. of Toyama, 5. Insti. of Nat. Med., Univ. of Toyama, 6. Research Center for Pre-Disease Science, Univ. of Toyama)

[28-57-pm1-05S]Analysis of the induction of epithelial-mesenchymal transition and its connection with PGI2 signaling in breast cancer cells

○Aya Yoshikawa1, Takuya Yamashita1, Tian-Qi Zhang2, Soshi Terada2, Yuma Kawamura1, Sae Wada1, Ryotaro Tsutsumi1, Kazuya Nagano1 (1. Sch. Pharm. Sci., Wakayama Medical Univ., 2. Grad. Sch. Pharm. Sci., UOsaka.)

[28-57-pm1-06S]TNFR2 Regulates M-MDSC Immunosuppression and Modulates Tumor Immunity

○Yuta Tsuji1, Masaki Inoue2, Shin-ichi Tsunoda1,2 (1. Grad. Sch. Pharm. Sci., Kobe Gakuin Univ., 2. Fac. Pharm. Sci., Kobe Gakuin Univ)

[28-57-pm1-07S]Analysis of B16BL6 melanoma cell proliferation suppression mechanism by a water-soluble extract from cultue medium of Lentinus edodes mycelia (LEM)

○Ayaka Tsugane1, Reina Sasaki1, Naohiro Iwata1, Yasuhide Hibino1, Dai Iizuka2, Shinya Kamiuchi1 (1. Fac. Pharm. & Phamceu. Sci., Josai Univ., 2. Noda Shokukin-kogyo Co., Ltd.)

[28-57-pm1-08S]Analysis of Lymph Node Metastasis Mechanisms Using Human Breast Cancer Cell Lines with High-Lymph Node Metastasis

○Akira Ishizu1, Shiho Suzuki1, Haruka Sakamoto1, Hana Arakaki1, Yukie Kaneko1, Hideki Yagi1 (1. Sch. Pharm. IUHW)

[28-57-pm1-09S]Potential of Anti-sphingosine 1-phosphate (S1P) receptor-1 (S1PR1) monoclonal antibodies as anti-cancer antibody therapeutics

○TAKUTO WADA1, Masaki Matsubara1, Young Mika Dan Jung1, Koudai Aizawa1, Momoka Saito1, Hideki Yagi1 (1. Sch.Pharm. IUHW)
Back to Category List